Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$4.77K Hold
428
﹤0.01% 306
2022
Q3
$4K Buy
428
+24
+6% +$236 ﹤0.01% 322
2022
Q2
$4K Hold
404
﹤0.01% 307
2022
Q1
$4K Hold
404
﹤0.01% 313
2021
Q4
$5K Sell
404
-1,480
-79% -$19.8K ﹤0.01% 294
2021
Q3
$26K Sell
1,884
-1
-0.1% -$14 ﹤0.01% 220
2021
Q2
$27K Sell
1,885
-68
-3% -$984 ﹤0.01% 225
2021
Q1
$27K Buy
+1,953
New +$31.8K ﹤0.01% 217

Other funds holding VTRS

Burleson & Co's VTRS Position: Q4 2022 in Review

Burleson & Co held its Viatris (VTRS) position steady in Q4 2022 at 428 shares worth $4.77K. The position accounts for ﹤0.01% of the portfolio, ranked #306.

Burleson & Co first reported a position in VTRS in Q1 2021 and has held it in 8 quarters since. The position peaked at $27K in Q2 2021. 1,016 funds tracked by Wall St. Rank hold VTRS as of Q4 2022.

  • Burleson & Co held 428 shares of Viatris worth $4.77K as of Q4 2022.
  • Burleson & Co left its Viatris share count unchanged in Q4 2022.
  • Viatris made up ﹤0.01% of Burleson & Co's portfolio in Q4 2022, its #306 holding.
  • Burleson & Co first reported a position in Viatris in Q1 2021 and has held it in 8 quarters since.
  • Burleson & Co's Viatris position peaked at $27K in Q2 2021.
  • 1,016 funds tracked by Wall St. Rank held Viatris as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.